Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice - Le, X; Sakai, H; Felip, E (Clin Cancer Res, 2022)
et al.